Skip to main content
BCTX logo

BCTX · BriaCell Therapeutics Corp.

$3.59 -0.13 (-3.49%) At close · Jul 24
Market Cap
$32.36M
Shares
8.70M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 15
Total Value: $1,620,695
Total Shares: 386,804

Institutional Ownership Trend

4 quarters

Holder Concentration

Across 16 13F filers
Top Holder
56.1%
Sep 2025 → Mar 2026 · range 41.3% – 88.9%
of institutional value
Top 5
98.8%
Sep 2025 → Mar 2026 · range 97.4% – 98.8%
of institutional value
Top 10
100.0%
Sep 2025 → Mar 2026 · range 99.8% – 100.0%
of institutional value
HHI
3,814
Sep 2025 → Mar 2026 · range 3,207 – 7,957
Highly concentrated
Showing 15 of 15
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1610820 CUSIP 107930307 13F (30d) 1 filings 1 filers Visit website Investor relations